4‑Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF‑α and regulating the expression of insulin signal transduction proteins

Gao,Feng; Jian,Liumeng; Zafar,Mohammad Ishraq; Du,Wen; Cai,Qin; Shafqat,Raja Adeel; Lu,Furong

doi:10.3892/mmr.2015.4298

4‑Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF‑α and regulating the expression of insulin signal transduction proteins

Authors:
- Feng Gao
- Liumeng Jian
- Mohammad Ishraq Zafar
- Wen Du
- Qin Cai
- Raja Adeel Shafqat
- Furong Lu
View Affiliations

Affiliations: Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China, Department of Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China, Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China
Published online on: September 7, 2015 https://doi.org/10.3892/mmr.2015.4298
Pages: 6555-6560
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have indicated that 4‑hydroxyisoleucine (4‑HIL) improves insulin resistance, however, the underlying mechanisms remain to be elucidated. In the present study, the molecular mechanisms underlying how 4‑HIL improves insulin resistance in hepatocytes were examined. HepG2 cells were co‑cultured with insulin and a high glucose concentration to obtain insulin‑resistant (IR) HepG2 cells. Insulin sensitivity was determined by measuring the glucose uptake rate. The IR HepG2 cells were treated with different concentrations of 4‑HIL to determine its effect on IR Hep2 cells. The levels of tumor necrosis factor‑α (TNF‑α) were measured by an enzyme‑linked immunosorbent assay and protein levels of TNF‑α converting enzyme (TACE)/tissue inhibitor of metalloproteinase 3 (TIMP3), insulin receptor substrate (IRS)‑1, IRS‑2, phosphorylated (p)‑IRS‑1 (Ser307) and glucose transporter type 4 (GLUT4) were measured by western blot analysis. The results of the present study demonstrated that insulin‑induced glucose uptake was reduced in IR HepG2 cells; however, this reduction was reversed by 4‑HIL in a dose‑dependent manner. 4‑HIL achieved this effect by downregulating the expression of TNF‑α and TACE, and upregulating the expression of TIMP3 in IR HepG2 cells. In addition, 4‑HIL increased the expression of the insulin transduction regulators IRS‑1 and GLUT4, and decreased the expression of p‑IRS‑1 (Ser307), without affecting the expression of IRS‑2. The present study suggests that 4‑HIL improved insulin resistance in HepG2 cells by the following mechanisms: 4‑HIL reduced TNF‑α levels by affecting the protein expression of the TACE/TIMP3 system and 4‑HIL stimulated the expression of IRS‑1 and GLUT4, but inhibited the expression of p‑IRS‑1 (Ser307).

View Figures

View References

1	Cordain L, Eades MR and Eades MD: Hyperinsulinemic diseases of civilization: More than just Syndrome X. Comp Biochem Physiol A Mol Integr Physiol. 136:95–112. 2003. View Article : Google Scholar : PubMed/NCBI
2	Xie W, Wang W, Su H, Xing D, Pan Y and Du L: Effect of ethanolic extracts of Ananas comosus L. leaves on insulin sensitivity in rats and HepG2. Comp Biochem Physiol C Toxicol Pharmacol. 143:429–435. 2006. View Article : Google Scholar : PubMed/NCBI
3	Peraldi P, Hotamisligil GS, Buurman WA, White MF and Spiegelman BM: Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem. 271:13018–13022. 1996. View Article : Google Scholar : PubMed/NCBI
4	Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, et al: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 385:733–736. 1997. View Article : Google Scholar : PubMed/NCBI
5	Bu R, Borysenko CW, Li Y, Cao L, Sabokbar A and Blair HC: Expression and function of TNF-family proteins and receptors in human osteoblasts. Bone. 33:760–770. 2003. View Article : Google Scholar : PubMed/NCBI
6	Moreira AP, Dias-Melicio LA, Peraçoli MT, Calvi SA and Victoriano de Campos Soares AM: Killing of Paracoccidioides brasiliensis yeast cells by IFN-gamma and TNF-alpha activated murine peritoneal macrophages: Evidence of H (2)O (2) and NO effector mechanisms. Mycopathologia. 166:17–23. 2008. View Article : Google Scholar : PubMed/NCBI
7	Takahashi E, Okumura A, Unoki-Kubota H, Hirano H, Kasuga M and Kaburagi Y: Differential proteome analysis of serum proteins associated with the development of type 2 diabetes mellitus in the KK-A(y) mouse model using the iTRAQ technique. J Proteomics. 84:40–51. 2013. View Article : Google Scholar : PubMed/NCBI
8	Saghizadeh M, Ong JM, Garvey WT, Henry RR and Kern PA: The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest. 97:1111–1116. 1996. View Article : Google Scholar : PubMed/NCBI
9	Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K and Yano Y: Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 83:859–862. 1998.PubMed/NCBI
10	Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A and White MF: Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest. 107:181–189. 2001. View Article : Google Scholar : PubMed/NCBI
11	del Aguila LF, Claffey KP and Kirwan JP: TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol. 276:E849–E855. 1999.PubMed/NCBI
12	Krogh-Madsen R, Plomgaard P, Møller K, Mittendorfer B and Pedersen BK: Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. Am J Physiol Endocrinol Metab. 291:E108–E114. 2006. View Article : Google Scholar : PubMed/NCBI
13	Tang ZY, Loss G, Carmody I and Cohen AJ: TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats. Transplantation. 82:1518–1523. 2006. View Article : Google Scholar : PubMed/NCBI
14	Narender T, Puri A, Shweta Khaliq T, Saxena R, Bhatia G and Chandra R: 4-hydroxyisoleucine an unusual amino acid as anti-dyslipidemic and antihyperglycemic agent. Bioorg Med Chem Lett. 16:293–296. 2006. View Article : Google Scholar
15	Jetté L, Harvey L, Eugeni K and Levens N: 4-Hydroxyisoleucine: A plant-derived treatment for metabolic syndrome. Curr Opin Investig Drugs. 10:353–358. 2009.PubMed/NCBI
16	Sauvaire Y, Petit P, Broca C, Manteghetti M, Baissac Y, Fernandez-Alvarez J, Gross R, Roye M, Leconte A, Gomis R and Ribes G: 4-Hydroxyisoleucine: A novel amino acid potentiator of insulin secretion. Diabetes. 47:206–210. 1998. View Article : Google Scholar : PubMed/NCBI
17	Haefelé C, Bonfils C and Sauvaire Y: Characterization of a dioxygenase from Trigonella foenum-graecum involved in 4-hydroxyisoleucine biosynthesis. Phytochemistry. 44:563–566. 1997. View Article : Google Scholar : PubMed/NCBI
18	Broca C, Manteghetti M, Gross R, Baissac Y, Jacob M, Petit P, Sauvaire Y and Ribes G: 4-Hydroxyisoleucine: Effects of synthetic and natural analogues on insulin secretion. Eur J Pharmacol. 390:339–345. 2000. View Article : Google Scholar : PubMed/NCBI
19	Broca C, Breil V, Cruciani-Guglielmacci C, Manteghetti M, Rouault C, Derouet M, Rizkalla S, Pau B, Petit P, Ribes G, et al: Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat. Am J Physiol Endocrinol Metab. 287:E463–E471. 2004. View Article : Google Scholar : PubMed/NCBI
20	Savage DB, Petersen KF and Shulman GI: Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension. 45:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
21	Haeri MR, Izaddoost M, Ardekani MR, Nobar MR and White KN: The effect of fenugreek 4-hydroxyisoleucine on liver function biomarkers and glucose in diabetic and fructose-fed rats. Phytother Res. 23:61–64. 2009. View Article : Google Scholar
22	Henkel J, Neuschäfer-Rube F, Pathe-Neuschäfer-Rube A and Püschel GP: Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes. Hepatology. 50:781–790. 2009. View Article : Google Scholar : PubMed/NCBI
23	Ogawa J, Kodera T, Smirnov SV, Hibi M, Samsonova NN, Koyama R, Yamanaka H, Mano J, Kawashima T, Yokozeki K and Shimizu S: A novel L-isoleucine metabolism in Bacillus thuringiensis generating (2S,3R,4S)-4-hydroxyisoleucine, a potential insulinotropic and anti-obesity amino acid. Appl Microbiol Biotechnol. 89:1929–1938. 2011. View Article : Google Scholar
24	Zhang WY, Lee JJ, Kim IS, Kim Y, Park JS and Myung CS: 7-O-methylaromadendrin stimulates glucose uptake and improves insulin resistance in vitro. Biol Pharm Bull. 33:1494–1499. 2010. View Article : Google Scholar : PubMed/NCBI
25	Khan AH and Pessi JE: Insulin regulation of glucose uptake: A complex interplay of intracellular signalling pathways. Diabetologia. 45:1475–1483. 2002. View Article : Google Scholar : PubMed/NCBI
26	Wang Q, Somwar R, Bilan PJ, Liu Z, Jin J, Woodgett JR and Klip A: Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol. 19:4008–4018. 1999. View Article : Google Scholar : PubMed/NCBI
27	Miura A, Ishizuka T, Kanoh Y, Ishizawa M, Itaya S, Kimura M, Kajita K and Yasuda K: Effect of tumor necrosis factor-alpha on insulin signal transduction in rat adipocytes: Relation to PKCbeta and zeta translocation. Biochim Biophys Acta. 1449:227–238. 1999. View Article : Google Scholar : PubMed/NCBI
28	Tal R, Pavlovsky L and David M: Psoriasis and cardiovascular risk factors. Harefuah. 151:573–575. 2012.In Hebrew.
29	Xin-Long C, Zhao-Fan X, Dao-Feng B and Wei D: mTOR partly mediates insulin resistance by phosphorylation of insulin receptor substrate-1 on serine (307) residues after burn. Burns. 37:86–93. 2011. View Article : Google Scholar
30	Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF and Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 271:665–668. 1996. View Article : Google Scholar : PubMed/NCBI
31	Monroy A, Kamath S, Chavez AO, Centonze VE, Veerasamy M, Barrentine A, Wewer JJ, Coletta DK, Jenkinson C, Jhingan RM, et al: Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: A new mechanism of insulin resistance in humans. Diabetologia. 52:2169–2181. 2009. View Article : Google Scholar : PubMed/NCBI
32	Federici M, Hribal ML, Menghini R, Kanno H, Marchetti V, Porzio O, Sunnarborg SW, Rizza S, Serino M, Cunsolo V, et al: Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest. 115:3494–3505. 2005. View Article : Google Scholar : PubMed/NCBI
33	Serino M, Menghini R, Fiorentino L, Amoruso R, Mauriello A, Lauro D, Sbraccia P, Hribal ML, Lauro R and Federici M: Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes. Diabetes. 56:2541–2546. 2007. View Article : Google Scholar : PubMed/NCBI
34	Smookler DS, Mohammed FF, Kassiri Z, Duncan GS, Mak TW and Khokha R: Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol. 176:721–725. 2006. View Article : Google Scholar : PubMed/NCBI